CSBR:NASDAQ
Champions Oncology Inc
USDÂ 4,51
arrow_downward
-1,78%(-0,082) 1D
18 Nov., 14:08:04 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
USDÂ 4,55
High
USDÂ 4,60
Low
USDÂ 4,41
Mkt. cap
62,80Â m
Avg. vol.
7,41Â k
Volume
10,85Â k
52-wk high
USDÂ 8,31
52-wk low
USDÂ 4,41
EPS
-USDÂ 0,08
Beta
0,47
Shares outstanding
13,92Â m
No. of employees
217
Open
USDÂ 4,55
High
USDÂ 4,60
Low
USDÂ 4,41
Mkt. cap
62,80Â m
Avg. vol.
7,41Â k
Volume
10,85Â k
52-wk high
USDÂ 8,31
52-wk low
USDÂ 4,41
EPS
-USDÂ 0,08
Beta
0,47
Shares outstanding
13,92Â m
No. of employees
217
News stories
From web sources and news partners
MarketWatch
·
15 minute gelede
Nasdaq on track for best outperformance of Dow and S&P 500 in more than a week
Yahoo Finance
·
1 uur gelede
If You'd Invested $1,000 in an S&P 500 ETF Ahead of the Dot-Com Bubble, Here's What You'd Have Today
Hedgeye
·
5 uur gelede
Why Negative Gamma Has Taken the Brakes Off the S&P 500
Talking Biz News
·
2 uur gelede
Dow Jones News Fund names four to board
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, New Jersey, Verenigde State van Amerika
SectorHealth Care
Industry-
Websitechampionsoncology.com